EyePoint Pharmaceuticals Inc (EYPT)
16.16
-0.31
(-1.88%)
USD |
NASDAQ |
Apr 25, 16:00
16.16
0.00 (0.00%)
After-Hours: 20:00
EyePoint Pharmaceuticals Total Liabilities (Quarterly): 88.86M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 88.86M |
| September 30, 2023 | 101.42M |
| June 30, 2023 | 118.39M |
| March 31, 2023 | 76.20M |
| December 31, 2022 | 83.99M |
| September 30, 2022 | 84.14M |
| June 30, 2022 | 82.07M |
| March 31, 2022 | 77.74M |
| December 31, 2021 | 78.99M |
| September 30, 2021 | 75.50M |
| June 30, 2021 | 71.96M |
| March 31, 2021 | 71.43M |
| December 31, 2020 | 73.18M |
| September 30, 2020 | 69.20M |
| June 30, 2020 | 65.50M |
| March 31, 2020 | 63.82M |
| December 31, 2019 | 64.64M |
| September 30, 2019 | 63.13M |
| June 30, 2019 | 63.12M |
| March 31, 2019 | 61.98M |
| September 30, 2018 | 41.15M |
| June 30, 2018 | 59.98M |
| March 31, 2018 | 41.96M |
| December 31, 2017 | 4.292M |
| September 30, 2017 | 4.326M |
| Date | Value |
|---|---|
| June 30, 2017 | 5.341M |
| March 31, 2017 | 4.995M |
| December 31, 2016 | 4.984M |
| September 30, 2016 | 10.48M |
| June 30, 2016 | 10.74M |
| March 31, 2016 | 9.612M |
| December 31, 2015 | 9.526M |
| September 30, 2015 | 8.637M |
| June 30, 2015 | 8.999M |
| March 31, 2015 | 7.855M |
| December 31, 2014 | 7.905M |
| September 30, 2014 | 7.938M |
| June 30, 2014 | 7.747M |
| March 31, 2014 | 7.675M |
| December 31, 2013 | 8.22M |
| September 30, 2013 | 8.498M |
| June 30, 2013 | 8.549M |
| March 31, 2013 | 7.879M |
| December 31, 2012 | 7.232M |
| September 30, 2012 | 7.176M |
| June 30, 2012 | 6.961M |
| March 31, 2012 | 7.278M |
| December 31, 2011 | 7.155M |
| September 30, 2011 | 7.908M |
| June 30, 2011 | 9.68M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
63.12M
Minimum
Jun 2019
118.39M
Maximum
Jun 2023
77.54M
Average
75.50M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| INVO Bioscience Inc | 20.00M |
| Bio-Path Holdings Inc | 2.779M |
| Ocular Therapeutix Inc | 160.93M |
| Aileron Therapeutics Inc | 99.12M |
| Apellis Pharmaceuticals Inc | 594.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 355.18M |
| Shareholders Equity (Quarterly) | 266.32M |
| Current Ratio | 5.450 |
| Net Debt Paydown Yield | 0.70% |